FDA’s Technology Plan Will Wound, But Not Kill, Paper Submissions By 2012
Executive Summary
FDA is seeking comment on the next steps the agency plans to take under the fourth extension of the Prescription Drug User Fee Act in order to move towards its vision of eliminating paper for the submission and review of all regulatory documents